During a recent fireside chat, executives from Varex Imaging (NASDAQ:VREX), including CFO Sam Maheshwari and Director of Investor Relations Chris Belfiore, provided insights into the company's business model, prevailing market demands, and strategic growth initiatives. The discussion centered on Varex's long-standing specialization in X-ray-based imaging, a field it has dominated for over half a century. The company's operations are distinctly divided into two primary segments: medical, which contributes approximately 70% of its total revenue, and industrial, accounting for the remaining 30%. Varex supplies essential components such as X-ray tubes, detectors, and associated software, serving a vast global network of medical imaging OEMs including industry giants like GE, Siemens, Philips, Canon, and Hologic, as well as industrial clients such as OSI Systems, Zeiss, and Thermo Fisher.
A significant portion of the conversation addressed Varex's proactive measures to manage tariff impacts and expand its manufacturing footprint. Maheshwari elaborated on the company's success in largely passing increased tariff costs to customers and implementing mitigation strategies, such as localized production in China and Europe, alongside establishing local supply chains and utilizing bonded warehouses. He also revealed the company's ambitious plan to construct two new manufacturing facilities in India, one for detector production already operational and shipping, and another for radiographic tubes slated for completion by year-end. These Indian plants are designed to target price-sensitive market segments, aiming to enhance Varex's competitive edge and reclaim lost market share, particularly in regions where analog film imaging is still prevalent, like South Asia and parts of Latin America, China, and Indonesia. Furthermore, Varex is actively pursuing growth in industrial cargo inspection systems, having secured $55 million in fiscal 2025 bookings, driven by increasing demand for border security and manifest verification. The company is also at the forefront of photon-counting technology, which promises significant advancements in medical imaging through dose reduction and improved image quality, and offers high-speed imaging capabilities for diverse industrial applications, including the inspection of packaged goods and EV batteries.
Looking forward, Varex Imaging is poised for continued innovation and market leadership, underpinned by its strategic investments and focus on advanced imaging technologies. The company’s efforts in navigating global trade complexities, expanding into new geographical markets, and developing cutting-edge solutions like photon counting and cargo inspection systems demonstrate a commitment to both short-term profitability and long-term sustainable growth. By addressing challenges and capitalizing on opportunities within the dynamic medical and industrial imaging landscapes, Varex Imaging not only aims to solidify its market position but also contribute to advancements that benefit healthcare, security, and various industrial sectors worldwide. This forward-thinking approach ensures that Varex remains a vital player in shaping the future of X-ray imaging technology.